whytestocks
5 years ago
News: $XOMA XOMA to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the 2019 H.C. Wainwright Global Life Sciences in London, United Kingdom. The pres...
In case you are interested https://marketwirenews.com/news-releases/xoma-to-present-at-the-2019-h-c-wainwright-global-life-sciences-conference-7938960.html
jdlamont
6 years ago
IF any of xoma's clients come up with a drug, there is going to be a rush to buy out xoma. they could save all the royalty payments and collect royalty payments from others by doing so.
This stock still has dangerous upside.
They are in the hottest biotech field right now, antibodies for cancer and other diseases, including infections.
antibiotics are hard to come by and have narrow usage.
true, stock looks expensive, but they only have 8 million O/S!